|
Balance Sheet Cash Flow Statement 9000 State Rd. Philadelphia, PA 19136-1615 PA Tel. 215-333-9000 Toll Free 800-325-9994 Fax 215-333-9004 |
Type: Public
On the web:
http://www.lannett.com
Employees:
277
Employee growth: 24.8%
Lannett banks on the designation of "bioequivalent" for its products. The firm manufactures and markets generic prescription drugs including painkillers (including two versions of Novartis' migraine treatment Fiorinal), anticonvulsants for epileptics, and Digoxin for congestive heart failure (a version of Lanoxin). The company has also developed a generic version of Abbott Laboratories' Synthroid. While it manufactures some of its products, Jerome Stevens Pharmaceuticals manufactures a significant portion of Lannett's inventories. Lannett prefers to focus on products with few generic competitors. Chairman William Farber and his family own more than half of the company.
Key numbers for fiscal year ending June, 2009:
Sales: $119.0M
One year growth: 64.4%
Net income: $6.5M
Officers:
Chairman: William Farber
President, CEO, and Director: Arthur P. Bedrosian
VP Operations: Stephen J. Kovary
Competitors:
King Pharmaceuticals
Mylan
Watson Pharmaceuticals




